Cancer/testis antigen 1 (119-138)

Cancer/testis antigen 1 (119-138) is a synthetic peptide fragment derived from the cancer/testis antigen 1 (CTAG1), also known as NY-ESO-1, which is a well-characterized member of the cancer/testis antigen family. This peptide encompasses amino acid residues 119 to 138 of the full-length protein, a segment recognized for its immunological relevance and specific expression profile in various malignancies and germ cells. Due to its restricted presence in normal adult tissues and high immunogenicity, the 119-138 epitope has become a focal point in tumor immunology research, vaccine development, and studies exploring antigen processing and presentation. Its defined sequence and established immunodominance make it a valuable tool for dissecting cellular and molecular mechanisms underpinning cancer-associated immune responses.

Epitope mapping: The 119-138 peptide segment is widely utilized for precise epitope mapping studies, enabling researchers to delineate the antigenic determinants recognized by cytotoxic T lymphocytes and helper T cells. By incorporating this peptide into in vitro assays, investigators can identify specific T-cell receptor interactions, characterize immunodominant regions, and evaluate the cross-reactivity of immune responses among different HLA alleles. Such mapping is critical for understanding the breadth and specificity of anti-tumor immunity elicited by CTAG1 and related antigens.

Immunogenicity assessment: Researchers employ this peptide in functional assays to assess its capacity to stimulate antigen-specific T-cell responses. Using peripheral blood mononuclear cells or tumor-infiltrating lymphocytes, the 119-138 epitope serves as a model antigen for evaluating cytokine production, proliferation, and cytolytic activity. These studies are essential for determining the immunogenic potential of CTAG1-derived sequences and for optimizing peptide-based immunotherapeutic strategies.

Vaccine development research: The defined sequence of this peptide makes it a prominent candidate in preclinical investigations of peptide-based cancer vaccines. By incorporating the 119-138 epitope into vaccine formulations, scientists can examine antigen processing, presentation, and the induction of robust cellular immune responses. Experimental models utilizing this peptide contribute to the rational design of immunization protocols, adjuvant selection, and combination strategies aimed at enhancing anti-tumor efficacy.

Antigen processing and presentation studies: The peptide is instrumental in elucidating the mechanisms of MHC class I and II antigen processing and presentation. By studying its uptake, intracellular trafficking, and presentation on antigen-presenting cells, researchers gain insights into the efficiency of peptide loading, the influence of proteasomal cleavage, and the determinants of immunodominance. These mechanistic studies support the development of improved antigen delivery systems and inform strategies to potentiate immune recognition of tumor antigens.

Analytical assay development: The 119-138 peptide is frequently employed as a standard or positive control in various analytical platforms, including enzyme-linked immunospot (ELISPOT) assays, flow cytometry-based tetramer staining, and enzyme-linked immunosorbent assays (ELISA). Its well-defined sequence and established immunological activity facilitate assay calibration, validation, and quality control, ensuring reliable detection and quantification of antigen-specific immune responses in basic and translational research settings.

1. Extended exenatide administration enhances lipid metabolism and exacerbates pancreatic injury in mice on a high fat, high carbohydrate diet

2. Therapeutic potential of an intestinotrophic hormone, glucagon-like peptide 2, for treatment of type 2 short bowel syndrome rats with intestinal bacterial and fungal dysbiosis

3. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review

4. Odorant binding protein based biomimetic sensors for detection of alcohols associated with Salmonella contamination in packaged beef

5. Emu oil in combination with other active ingredients for treating skin imperfections